Stay updated on Sotatercept in PAH: New Intermediate-High Risk Clinical Trial

Sign up to get notified when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, representing a recent update in the study record of a clinical trial evaluating the effects of sotatercept treatment on pulmonary arterial hypertension (PAH) patients who are newly diagnosed and at intermediate or high risk of disease progression.
    Difference
    0.0%
    Check dated 2024-06-06T16:06:03.000Z thumbnail image
  4. Check
    5 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change represents an update in the estimated primary completion date for the study of Sotatercept in newly diagnosed intermediate- and high-risk PAH participants.
    Difference
    0.0%
    Check dated 2024-06-04T06:54:37.000Z thumbnail image
  5. Check
    6 days ago
    No Change Detected
  6. Check
    8 days ago
    Change Detected
    Summary
    The value 04 08 97232 14000 Hopital de la Cote de Nacre - Caen CHRU LA MILETRIE 04 05 04 08 04 has recently changed to 05 31 97239 14033 CHU Caen Normandie CHU de Poitiers or triple (if any) 05 30 (Estimated) 05 31 05. This change likely represents an update in medical and healthcare-related information on the webpage.
    Difference
    0.8%
    Check dated 2024-06-01T03:00:09.000Z thumbnail image
  7. Check
    18 days ago
    Change Detected
    Summary
    The value 'Participation Criteria Collaborators - No information provided' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change indicates a shift in the webpage content towards specific criteria researchers are seeking in participants, possibly related to medical and healthcare-related publications and documentation.
    Difference
    20%
    Check dated 2024-05-22T07:33:16.000Z thumbnail image
  8. Check
    39 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2024-04-30T22:36:26.000Z thumbnail image

Stay in the know with updates to Sotatercept in PAH: New Intermediate-High Risk Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.